TAYSHA GENE THERAPIES INC. - COMMON STOCK

Taysha Gene Therapies to Release Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11

09 авг 2022 16:22:13 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies to Participate in Upcoming William Blair Biotech Focus Conference 2022

06 июл 2022 06:00:00 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies Announces Annual Stockholder Meeting

13 июн 2022 07:39:29 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies to Participate in Upcoming June Investor Conferences and Convention

02 июн 2022 06:00:00 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

16 май 2022 06:00:01 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies to Release First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 16

11 май 2022 06:00:00 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies Announces Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy

10 май 2022 06:00:02 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies Receives Orphan Drug Designation from the European Commission for TSHA-120 for the Treatment of Giant Axon Neuropathy (GAN)

03 май 2022 06:00:01 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies Announces Oral Presentations at the Upcoming 2022 IRSF Rett Syndrome Scientific Symposium and the ASCEND National Summit

25 апр 2022 06:00:00 Источник Nasdaq GlobeNewswire

Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell Therapy Manufacturing Summit

18 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire